Table 1 Demographic summary of NEER and PCAWG subset

From: Polygenic risk scores for autoimmune related diseases are significantly different in cancer exceptional responders

 

NEER

PCAWG

N

51

414

Male, n(%)

20 (39.2%)

154 (37.2%)

Age, median (IQR)

66 [62,70]

62 [51,71]

Organ System, n(%)

  

Breast

13 (25.5%)

106 (25.6%)

Pancreas

7 (13.7%)

57 (13.8%)

Lung

5 (9.8%)

41 (9.9%)

Leukemia

4 (7.8%)

33 (8.0%)

Ovary

4 (7.8%)

33 (8.0%)

Kidney

3 (5.9%)

24 (5.8%)

Uterus

3 (5.9%)

24 (5.8%)

Brain

2 (3.9%)

16 (3.9%)

Intestine

2 (3.9%)

16 (3.9%)

Melanoma

2 (3.9%)

16 (3.9%)

Bladder

1 (2.0%)

8 (1.9%)

Bone

1 (2.0%)

8 (1.9%)

Esophagus or Stomach

1 (2.0%)

8 (1.9%)

Gallbladder or Liver

1 (2.0%)

8 (1.9%)

Prostate

1 (2.0%)

8 (1.9%)

Thyroid

1 (2.0%)

8 (1.9%)

Cancer Stage, n(%)

  

Binet A

0 (0.0%)

18 (4.3%)

Binet B

0 (0.0%)

4 (1.0%)

Binet C

1 (2.0%)

2 (0.5%)

I

0 (0.0%)

42 (10.1%)

II

0 (0.0%)

59 (14.3%)

III

2 (3.9%)

31 (7.5%)

IV

43 (84.3%)

3 (0.7%)

NA

5 (9.8%)

225 (61.6%)

Vital Status, n(%)

  

Alive

47 (92.2%)

266 (64.3%)

Deceased

4 (7.8%)

126 (30.4%)

NA

 

22 (5.3%)

Years survived (censored), median (IQR)

12.77 [9.01,18.04]

2.89 [1.35,5.21]